- Home
- ITRG vs BNTC Comparison
ITRG vs BNTC Comparison
Compare ITRG & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ITRG | BNTC |
|---|---|---|
| Founded | 1997 | 1995 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.5M | 405.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ITRG | BNTC |
|---|---|---|
| Price | $3.93 | $12.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $4.13 | ★ $27.67 |
| AVG Volume (30 Days) | ★ 1.9M | 222.4K |
| Earning Date | 11-12-2025 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $219,125,000.00 | N/A |
| Revenue This Year | $965.93 | N/A |
| Revenue Next Year | $9.39 | N/A |
| P/E Ratio | $49.23 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.79 | $9.70 |
| 52 Week High | $4.69 | $17.15 |
Technical Indicators
Market Signals| Indicator | ITRG | BNTC |
|---|---|---|
| Relative Strength Index (RSI) | 50.02 | 45.49 |
| Support Level | $3.69 | $11.21 |
| Resistance Level | $4.10 | $12.71 |
| Average True Range (ATR) | 0.23 | 0.94 |
| MACD | -0.08 | -0.02 |
| Stochastic Oscillator | 23.00 | 44.66 |
Price Performance
Historical ComparisonAbout ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.